Milhem MM, Zakharia Y, Davar D, Buchbinder EI, et al. Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study. Cancer 2025;131:e70022.
PMID: 40753466